Inclusions and exclusions for the 62 day indicator The following inclusions and exclusions are detailed for the FCT 62 day indicator. Grouping Patients are included in the 62 day indicator if they Patients are excluded from the 62 day indicator if they Eligibility Are eligible for treatment in New Zealand Are not eligible for treatment in New Zealand Cancer pathway start point Have a pathway that begins inside the NZ health system Have a cancer that was diagnosed publicly Have entered the cancer pathway through an acute presentation, as long as there is a subsequent referral to an outpatient clinic Have received treatment for metastatic cancer where the primary site is unknown Have a pathway that begins outside the New Zealand health system Have a cancer that has been diagnosed through a screening programme Have a cancer that was diagnosed privately Have entered the cancer pathway through an acute presentation, which does not subsequently result in a referral to an outpatient clinic Have a recurrent cancer (irrespective of the time frame of recurrence) Have metastatic cancer, but the patient’s primary cancer has already been included in FCT reporting Age of patient Are under the care of adult services and are 16 or older at the date of first cancer treatment Are not under the care of adult services and/or are not 16 or older at the date of first cancer treatment Treatment Have received a first treatment (or other management) for cancer that is publicly funded, in the reporting period Have not received a first treatment (or other management) for cancer that is publicly funded, in the reporting period Have a first treatment for cancer that was undertaken privately Triage Have been triaged as having a high suspicion of cancer and as having a need to be seen within two weeks Have been triaged as not having a high suspicion of cancer Have a confirmed diagnosis of cancer at triage of referral Have been triaged as not needing to be seen within two weeks Primary diagnosis Have a primary diagnosis of cancer that is included in Appendix B of this document Have a primary diagnosis that is not included in Appendix B of this document
NMH Nelson Marlborough WCO West Coast CHC Canterbury HSC South Canterbury SRN Southern Appendix B: Primary site ICD codes The ICD codes should be recorded to the third digit for all cancers. The ICD codes to be reported are provided in the following table. Note that D codes are excluded from the FCT indicators because they relate to cancers that are low-risk, or non-invasive, or non-malignant, or low-grade, asymptomatic or indolent. ICD codes to third digit Description Cancer site group Effective date C00 Malignant neoplasm of lip Head and neck 01/01/2012 C01 Malignant neoplasm of base of tongue Head and neck 01/01/2012 C02 Malignant neoplasm of other and unspecified parts of tongue Head and neck 01/01/2012 C03 Malignant neoplasm of gum Head and neck 01/01/2012 C04 Malignant neoplasm floor of mouth Head and neck 01/01/2012 C05 Malignant neoplasm of palate Head and neck 01/01/2012 C06 Malignant neoplasm other and unspecified parts of the mouth Head and neck 01/01/2012 C07 Malignant neoplasms of parotid gland Head and neck 01/01/2012 C08 Malignant neoplasm other and unspecific part of salivary gland Head and neck 01/01/2012 C09 Malignant neoplasm of tonsil Head and neck 01/01/2012